Concepedia

Katy Knight

KK

Statistics

Publications

7

Citations

328

H-Index

7

Active since

2006

Affiliations

University of Liverpool(Current)

Royal Liverpool University Hospital

Katy Knight is an author at University of Liverpool specializing in hematology, medicine, and chronic myeloid leukemia therapy.

Publications per year

2006–2013

7

Publications

7

Clinical evaluation of BCR-ABL peptide immunisation in chronic myeloid leukaemia: results of the EPIC study

José M. Rojas, Katy Knight, L Wang et al. · Leukemia · 2007 · 109 citations

Medicine, Immunology, Oncology +11

The role of serial BCR-ABL transcript monitoring in predicting the emergence of BCR-ABL kinase mutations in imatinib-treated patients with chronic myeloid leukemia.

Lihui Wang, Katy Knight, Claire Lucas · PubMed · 2006 · 63 citations

Medicine, Hematology, Oncology +11

Simultaneous determination of nilotinib, imatinib and its main metabolite (CGP-74588) in human plasma by ultra-violet high performance liquid chromatography

Andrea Davies, Alison K. Hayes, Katy Knight et al. · Leukemia Research · 2009 · 60 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

A prospective evaluation of cardiac function in patients with chronic myeloid leukaemia treated with imatinib

Zahra Raisi‐Estabragh, Katy Knight, Sarah Watmough et al. · Leukemia Research · 2010 · 54 citations

Medicine, Cardiology, Hematology +8

Naturally occurring CD4+ CD25+ FOXP3+ T-regulatory cells are increased in chronic myeloid leukemia patients not in complete cytogenetic remission and can be immunosuppressive

José M. Rojas, Lihui Wang, Sally Owen et al. · Experimental Hematology · 2010 · 18 citations

Life Sciences, Hematology, Immunology +16

1–5 of 7